Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced their participation at the annual Drug Development Boot Camp November 15-16, 2017 at the Harvard Club in Boston, MA. The Drug Development Boot Camp is hosted by Speid & Associates, Inc., in coordination with Harvard's Office of Technology Development, and is a two-day intensive program for executive-level individuals that involves hands-on learning about the drug development process.
John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath, will present a systems pharmacology (mechanistic PK/PD) modeling workshop at the event. Dr. Burke's presentation reviews a case study and ends with a hands-on workshop where attendees work through an interactive systems pharmacology example. "I'm looking forward to another year of instructing at the Drug Development Boot Camp," said John Burke, PhD, Co-Founder, President, and CEO of Applied BioMath. "We always have a great time with the interactive workshop, watching researchers who are new to systems pharmacology walk through an example that helps them understand the value it can bring."
Modeling and simulation approaches continue to gain momentum in drug development due to their potential to save companies significant costs and shorten research timelines. Dr. Burke's presentation will highlight recent results from Applied BioMath's collaborations in biotech and pharma. He will demonstrate how Applied BioMath's modeling approach differs from existing approaches, and how this unique methodology results in prediction approaches, which when validated in the clinic, were proven to be 10x more accurate than accepted industry standards.
This will be Dr. Burke's fourth year participating in the Drug Development Boot Camp. To maintain an event of this caliber, speakers and participants are limited to those with proven a track record of drug development experience.
About Applied BioMath
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, helps biotechnology and pharmaceutical companies answer complex, critical Go/No-go decisions in R&D. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and decades of industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. Our involvement shortens project timelines, lowers cost, and increases the likelihood of a best-in-class drug. We provide clarity to complex situations, answer otherwise unanswerable questions, and our approach, when validated in the clinic, is 10x more accurate than traditional methodologies.
Applied BioMath and the Applied BioMath logo are registered trademarks of Applied BioMath, LLC.